In the latter paper, Ref-1 overexpression was associated with resistance to cisplatin and, on the contrary, Ref-1 downregulation via siRNA enhanced the sensitivity of A549 NSCLC cells to chemotherapy [22]. The gene discussed is APEX1; the disease is non-small cell lung carcinoma.